Orthopedic Biomaterials Articles & Analysis
6 news found
Also in July 2021, Celularity entered into an exclusive supply and distribution agreement for multiple commercial products with Arthrex to distribute and commercialize Celularity’s biomaterial products for orthopedic surgery and sports medicine. In August 2021, Celularity entered into an exclusive strategic partnership to develop the combination of ...
Maxx Orthopedics, in Partnership with Invibio Biomaterial Solutions, Announces First Primary Total Knee Arthroplasty with the PEEK-OPTIMA™ Femoral Component. ...
Its new name, RevBio, was chosen since it more accurately portrays the objective of developing its revolutionary Tetranite® bone adhesive biomaterial platform. The company has also adapted a tag line "Transforming Bone Repair" which better defines the company's musculoskeletal focus in developing products for both dental and orthopedic applications where its ...
Graftys, a French Société Anonyme specialized in the development, manufacturing and commercialization of synthetic orthopedic biomaterials, announced today the appointment of its Chairman of the Board, Gilles Alberici, as Chief Executive Officer, effective January 20, 2016. ...
ByGraftys
Aix-en-Provence, November 16th, 2015 – GRAFTYS SA, a company which develops and commercializes biomaterials used in orthopedic surgery, announces that it has recently established an ambitious Post Marketing Surveillance program, in the form of an internationally based registry of patients who have received implants of GRAFTYS® HBS and GRAFTYS® ...
ByGraftys
Aix-en-Provence, September 14th, 2015 – GRAFTYS SA, a company focused on development and commercialization of orthopedic biomaterials, is pleased to announce that it has obtained authorization from its notified body, NSAI (National Standards Authority of Ireland) for European commercialization for two of its cements (GRAFTYS® HBS and GRAFTYS® ...
ByGraftys